Browse
Recent Presentations
Recent Stories
Content Topics
Updated Contents
Featured Contents
PowerPoint Templates
Create
Presentation
Article
Survey
Quiz
Lead-form
E-Book
Presentation Creator
Create stunning presentation online in just 3 steps.
Pro
Get powerful tools for managing your contents.
Login
Upload
Uploads
(515)
Stories
(0)
Favorites
(0)
Followers
(87)
+ Follow
haven smith
Writer, Delveinsight Business Research
Author
515 Presentations
United States
https://www.delveinsight.com/
Joined 01/21/2020
Uploads
(515)
Favorites
(0)
Channels
(0)
Followers
(87)
Uploads
Roche’s Glofitamab
44 views
Braftovi shows a higher response rate in a triplet combination after adding Opdi
41 views
Closely watched Janssen and Legend Biotech's CAR-T cell therapy
54 views
Genmab/Abbvie’s Epcoritamab achieves a 100% response rate in patients with R/R f
52 views
Daiichi’s Patritumab, its third ADC making headway in HER3 expressing metastatic
29 views
Enhertu carving out a new space for itself in HER2 low patients
48 views
ASCO 2022 Conference
29 views
Newly Launched First in Class LAG-3 Combination Drug Opdualag
75 views
Encouraging results of nivolumab bevacizumab FOLFOXIRI
60 views
Teclistamab, a soon-to-be-approved bispecific antibody, demonstrates its promise
84 views
Vasomotor symptoms (Hot flashes/Night sweats) Infographics
40 views
Can Breyanzi be a hit CAR-T in second-line treatment after failing in the first-
46 views
Primary Hyperoxaluria Market Insight, Epidemiology And Market Forecast - 2032
47 views
The PROs Further Support Durvalumab Chemo in Becoming The New Standard of Care
41 views
Takeda’s Flagship Product Panitumumab (PAN) mFOLFOX6 Versus bevacizumab (BEV)
26 views
Making Way For Immunotherapy In The GI Cancers, Durvalumab To Become The New Sta
33 views
View All
